/Cencora%20Inc_%20logo%20on%20phone-by%20Robert%20Way%20via%20Shutterstock.jpg)
Founded in 1871, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) sources and distributes pharmaceutical products in the United States and internationally. Its U.S. Healthcare Solutions segment serves hospitals, pharmacies, clinics, and specialty providers with drugs, vaccines, plasma products, and related services, alongside data, logistics, and commercialization support. International Healthcare Solutions extends these capabilities overseas, offering pharmaceutical wholesale, global commercialization, and specialized biopharma logistics to healthcare providers worldwide.
The company has a market capitalization of $66 billion and is expected to release its Q1 2026 earnings results on Wednesday, Feb. 4, before the market opens. Ahead of this event, analysts anticipate Cencora to generate earnings of $4.04 per share, representing an increase of 8.3% from $3.73 per share reported in the same quarter last year. The company has surpassed the Street’s bottom-line estimates in each of the past four quarters.